Pharma's Almanac TV
PA TV
Follow the Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Current Issue
Archive
Reports
2021 Gene Therapy Report
2021 Biologics Report
2021 Sterile Drug Products Report
2021 API Market Report
2020 OSD Market Report
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Bioprocessing
27 Articles Available
0
2
Can't find what you're looking for? Try our
advanced search
.
Process Intensification
Factory of the Future Will Be a Convergence of Digital and Bioprocessing Technologies
PAO-02-21-CL-03
Single-Use Technology
Stainless Steel to Single-Use: How to Adapt to the Changing Landscape in SUT
PAP-Q4-20-CL-004
Industry Leader
Shaping the Future of Biopharma Through Next-Generation Contract Drug Manufacturing
PAP-Q4-20-CL-023
Antibody–Drug Conjugates
Preparing for the ADC Explosion with End-to-End Support
PAP-Q4-20-CL-014
Leadership
A CEO’s Perspective: Positioning a CDMO for Significant Growth
PAP-Q3-20-CL-008
Collaboration
Better Together: Collaborating to Simplify Complexities in Drug Development
PAP-Q3-20-CL-028
The Future of Healthcare
How Is Polpharma Biologics Evolving its Business Model to Meet the Future of Healthcare?
PAP-Q3-20-RT2-007
Vaccine Development
The Advantages of Implementing Plant-Based Vaccines
PAP-Q3-20-CL-021
Bispecific Antibody
Challenges of Manufacturing the Expanding Range of Bi/Multispecific Modalities
PAP-Q4-19-CL-022
Plant-Based
Proprietary Protein Therapeutics with Clinically Improved Profiles
PAP-Q4-19-CL-028
Bioprocessing
Facilitating Modern Bioprocessing with Real-Time Protein Titer Monitoring
PAP-Q3-19-CL-016
Speed to Market
FastPharming for Speed to Market
PTV-M08-19-BIO-008
Launch
IDEX Health & Science, LLC Launches Dedicated Protein Analyzer for Bioprocessing: Tridex™
PR-M07-19-NI-057
Biopharma
Bioprocess of the Future: What’s In it for Biomanufacturers?
PAP-Q2-2019-CL-026
Plant-Based Solutions
Plant-based Protein Expression for Rapid, Green Bioprocessing
PAP-Q2-2019-CL-022
Lifecycle Support
Speed and Customized Support from Gene to GMP Manufacturing
PAP-Q1-2019-CL-026
Market Prediction
The Global Single-Use Bioprocessing Mmarket is Anticipated to Reach Revenues of Approximately $7 Billion by 2024
PR-M12-18-NI-009
CDMO
Dedicated CDMO Services Meet Customer Needs in the Dynamic Biopharma Sector
PAP-Q3-18-CL-004
Innovation
Single-Use Operational Excellence Explained: Effective Lifecycle Management
PAP-Q4-17-CL-006
Bioprocessing
Brammer Bio Leverages Advanced Bioprocessing Technologies to Accelerate Capacity
PAO-M10-17-NI-002
Better Data in Bioprocessing
PTV-M03-17-IN-003
Bioprocessing Capacity is in High Demand
PAO-M04-17-NI-022
Bioprocessing Technologies Dominate INTERPHEX Exhibitor Awards
PAO-M04-17-NI-008
Nice Insight Annual Pharmaceutical Equipment Report
PAP-Q03-16-SF-001
«
0
2
»
